Alessia Lanari

3.2k total citations
34 papers, 1.7k citations indexed

About

Alessia Lanari is a scholar working on Physiology, Psychiatry and Mental health and Epidemiology. According to data from OpenAlex, Alessia Lanari has authored 34 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 12 papers in Psychiatry and Mental health and 9 papers in Epidemiology. Recurrent topics in Alessia Lanari's work include Alzheimer's disease research and treatments (11 papers), Acute Ischemic Stroke Management (9 papers) and Dementia and Cognitive Impairment Research (8 papers). Alessia Lanari is often cited by papers focused on Alzheimer's disease research and treatments (11 papers), Acute Ischemic Stroke Management (9 papers) and Dementia and Cognitive Impairment Research (8 papers). Alessia Lanari collaborates with scholars based in Italy, Belgium and Sweden. Alessia Lanari's co-authors include Lucilla Parnetti, Giorgio Silvestrelli, Daniele Tomassoni, Virgilio Gallai, Valeria Caso, Serena Amici, Francesco Corea, Francesco Amenta, Giancarlo Agnelli and Maurizio Paciaroni and has published in prestigious journals such as Stroke, Biological Psychiatry and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Alessia Lanari

33 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessia Lanari Italy 20 547 468 467 414 269 34 1.7k
Toshihiko Iwamoto Japan 30 975 1.8× 384 0.8× 213 0.5× 920 2.2× 523 1.9× 137 2.9k
Joanna Pera Poland 28 355 0.6× 663 1.4× 419 0.9× 175 0.4× 466 1.7× 100 2.7k
Hirofumi Sakurai Japan 24 673 1.2× 282 0.6× 117 0.3× 536 1.3× 298 1.1× 85 1.8k
Yoshinobu Wakisaka Japan 23 300 0.5× 360 0.8× 417 0.9× 138 0.3× 496 1.8× 62 1.6k
Nanchang Xie China 23 454 0.8× 487 1.0× 230 0.5× 215 0.5× 168 0.6× 69 1.6k
Chera L. Maarouf United States 21 791 1.4× 216 0.5× 104 0.2× 301 0.7× 332 1.2× 34 1.3k
Giorgio Silvestrelli Italy 19 212 0.4× 412 0.9× 750 1.6× 161 0.4× 174 0.6× 38 1.6k
Tim West United States 25 1.0k 1.8× 179 0.4× 209 0.4× 396 1.0× 230 0.9× 63 2.4k
Auli Verkkoniemi Finland 24 1.2k 2.2× 397 0.8× 117 0.3× 744 1.8× 404 1.5× 30 2.1k
Herbert Moessler United States 29 511 0.9× 260 0.6× 278 0.6× 232 0.6× 1.1k 4.2× 68 1.9k

Countries citing papers authored by Alessia Lanari

Since Specialization
Citations

This map shows the geographic impact of Alessia Lanari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessia Lanari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessia Lanari more than expected).

Fields of papers citing papers by Alessia Lanari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessia Lanari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessia Lanari. The network helps show where Alessia Lanari may publish in the future.

Co-authorship network of co-authors of Alessia Lanari

This figure shows the co-authorship network connecting the top 25 collaborators of Alessia Lanari. A scholar is included among the top collaborators of Alessia Lanari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessia Lanari. Alessia Lanari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
D’Amore, Cataldo, Maurizio Paciaroni, Giorgio Silvestrelli, et al.. (2013). Severity of acute intracerebral haemorrhage, elderly age and atrial fibrillation: Independent predictors of poor outcome at three months. European Journal of Internal Medicine. 24(4). 310–313. 17 indexed citations
2.
Silvestrelli, Giorgio, Alessia Lanari, & Andrea Droghetti. (2012). Ventilatory Disorders. Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences. 30. 90–93. 7 indexed citations
3.
Borroni, Barbara, Enrico Premi, C. Agosti, et al.. (2011). CSF Alzheimer's disease-like pattern in corticobasal syndrome: evidence for a distinct disorder. Journal of Neurology Neurosurgery & Psychiatry. 82(8). 834–838. 32 indexed citations
4.
Paciaroni, Maurizio, Giancarlo Agnelli, Walter Ageno, et al.. (2010). Risk factors for cerebral ischemic events in patients with atrial fibrillation on warfarin for stroke prevention. Atherosclerosis. 212(2). 564–566. 27 indexed citations
5.
Silvestrelli, Giorgio, et al.. (2010). Clinical Pharmacology and Vascular Risk~!2009-05-11~!2009-12-22~!2010-06-14~!. The Open Neurology Journal. 4(2). 64–72. 2 indexed citations
6.
Paciaroni, Maurizio, Giancarlo Agnelli, Valeria Caso, et al.. (2009). Acute Hyperglycemia and Early Hemorrhagic Transformation in Ischemic Stroke. Cerebrovascular Diseases. 28(2). 119–123. 72 indexed citations
7.
Amenta, Francesco, Alessia Lanari, Fiorenzo Mignini, et al.. (2009). Nicardipine use in cerebrovascular disease: A review of controlled clinical studies. Journal of the Neurological Sciences. 283(1-2). 219–223. 22 indexed citations
8.
Lanari, Alessia, et al.. (2007). Arterial Hypertension and Cognitive Dysfunction in Physiologic and Pathologic Aging of the Brain. The American Journal of Geriatric Cardiology. 16(3). 158–164. 11 indexed citations
9.
Vanderstichele, Hugo, K De Vreese, Kaj Blennow, et al.. (2006). Analytical performance and clinical utility of the INNOTEST® PHOSPHO-TAU(181P) assay for discrimination between Alzheimer's disease and dementia with Lewy bodies. Clinical Chemistry and Laboratory Medicine (CCLM). 44(12). 1472–80. 131 indexed citations
10.
Parnetti, Lucilla, Giorgio Silvestrelli, Alessia Lanari, et al.. (2006). Efficacy of Thrombolytic (rt-PA) Therapy in Old Stroke Patients: The Perugia Stroke Unit Experience. Clinical and Experimental Hypertension. 28(3-4). 397–404. 6 indexed citations
11.
Lanari, Alessia, Francesco Amenta, Giorgio Silvestrelli, Daniele Tomassoni, & Lucilla Parnetti. (2005). Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease. Mechanisms of Ageing and Development. 127(2). 158–165. 146 indexed citations
12.
Parnetti, Lucilla, et al.. (2005). Diagnosing prodromal Alzheimer's disease: Role of CSF biochemical markers. Mechanisms of Ageing and Development. 127(2). 129–132. 56 indexed citations
13.
Silvestrelli, Giorgio, Alessia Lanari, Lucilla Parnetti, Daniele Tomassoni, & Francesco Amenta. (2005). Treatment of Alzheimer's disease: From pharmacology to a better understanding of disease pathophysiology. Mechanisms of Ageing and Development. 127(2). 148–157. 51 indexed citations
14.
Parnetti, Lucilla, Valeria Caso, Annalisa Santucci, et al.. (2004). Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke. Neurological Sciences. 25(1). 13–17. 58 indexed citations
15.
Parnetti, Lucilla, et al.. (2003). Cerebrospinal fluid biochemical markers in early detection and in differential diagnosis of dementia disorders in routine clinical practice. Neurological Sciences. 24(3). 199–200. 17 indexed citations
16.
Parnetti, Lucilla, Serena Amici, Alessia Lanari, et al.. (2002). Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors. Neurological Sciences. 23(0). s95–s96. 61 indexed citations
17.
Parnetti, Lucilla, Valeria Caso, Serena Amici, et al.. (2002). HYPERHOMOCYST(E)INEMIA: A RISK FACTOR FOR CEREBROVASCULAR DISEASE. Clinical and Experimental Hypertension. 24(7-8). 501–509. 7 indexed citations
18.
Bottiglieri, Teodoro, Lucilla Parnetti, Erland Arning, et al.. (2001). Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene: a study in an Italian population with dementia. Mechanisms of Ageing and Development. 122(16). 2013–2023. 40 indexed citations
19.
Amici, Serena, Alessia Lanari, Rita Romani, et al.. (2001). Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina. Mechanisms of Ageing and Development. 122(16). 2057–2062. 34 indexed citations
20.
Parnetti, Lucilla, Alessia Lanari, Serena Amici, et al.. (2001). CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Neurological Sciences. 22(1). 77–78. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshihiko Iwamoto Breakdown of academic impact, for papers by Joanna Pera Breakdown of academic impact, for papers by Hirofumi Sakurai Breakdown of academic impact, for papers by Yoshinobu Wakisaka Breakdown of academic impact, for papers by Nanchang Xie Breakdown of academic impact, for papers by Chera L. Maarouf Breakdown of academic impact, for papers by Giorgio Silvestrelli Breakdown of academic impact, for papers by Tim West Breakdown of academic impact, for papers by Auli Verkkoniemi Breakdown of academic impact, for papers by Herbert Moessler
Rankless by CCL
2026